Skin tolerance: In search of the Holy Grail

Transplant International

Volumn 21, Issue 2, 2008, Pages 101-112

  Horner, Benjamin M ^a,b   Randolph, Mark A ^a   Huang, Christene A ^a   Butler, Peter E M ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Animal; Clinical; Research; Skin; Tolerance; Transplant

Indexed keywords

15 DEOXYSPERGUALIN; ANTIGEN; CD40 LIGAND MONOCLONAL ANTIBODY; CYCLOSPORIN; ENTEROCOCCAL POLYSACCHARIDE ANTIGEN; LF 15 0195; SKN ANTIGEN; UNCLASSIFIED DRUG;

ALLOIMMUNITY; CELL TRANSFER; DENDRITIC CELL; DISEASE MODEL; ENDOTHELIUM; GRAFT REJECTION; HEMATOPOIETIC CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; ISCHEMIA; LYMPHOCYTE DEPLETION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKIN ALLOGRAFT; SKIN BLOOD FLOW; SKIN CELL; SKIN GRAFT; SKIN STRUCTURE; T CELL DEPLETION;

ANIMALS; GRAFT REJECTION; HUMANS; IMMUNE TOLERANCE; MODELS, ANIMAL; SKIN TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 38049129287     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2007.00559.x     Document Type: Review

References (124)

1. Gibson T, Medawar PB. The fate of skin homografts in man. J Anat 1943 77 : 299.
2. Owen RD. Immunogenetic consequences of vascular anastomoses between bovine twins. Science 1945 102 : 400.
3. Billingham RE, Brent L, Medawar PB. Actively acquired tolerance to foreign cells. Nature 1953 172 : 603.
4. Lanzetta M, Petruzzo P, Margreiter R, et al. The international registry on hand and composite tissue transplantation. Transplantation 2005 79 : 1210.
5. Levi DM, Tzakis AG, Kato T, et al. Transplantation of the abdominal wall. Lancet 2003 361 : 2173.
6. Jiang HQ, Wang Y, Hu XB, Li YS, Li JS. Composite tissue allograft transplantation of cephalocervical skin flap and two ears. Plast Reconstr Surg 2005 115 : 31e.
7. Kanitakis J, Badet L, Petruzzo P, et al. Clinicopathologic monitoring of the skin and oral mucosa of the first human face allograft: report on the first eight months. Transplantation 2006 82 : 1610.
8. Inceoglu S, Siemionow M, Chick L, Craven CM, Lister GD. The effect of combined immunosuppression with systemic low-dose cyclosporin and topical fluocinolone acetonide on the survival of rat hind-limb allografts. Ann Plast Surg 1994 33 : 57.
9. Yuzawa K, Taniguchi H, Seino K, Otsuka M, Fukao K. Topical immunosuppression in skin grafting with FK 506 ointment. Transplant Proc 1996 28 : 1387.
10. Fujita T, Takahashi S, Yagihashi A, Jimbow K, Sato N. Prolonged survival of rat skin allograft by treatment with FK506 ointment. Transplantation 1997 64 : 922.
11. Eljaafari A, Badet L, Kanitakis J, et al. Isolation of regulatory T cells in the skin of a human hand-allograft, up to six years posttransplantation. Transplantation 2006 82 : 1764.
12. Ricordi C, Karatzas T, Nery J, et al. High-dose donor bone marrow infusions to enhance allograft survival - the effect of timing. Transplantation 1997 63 : 7.
13. Fehr T, Sykes M. Tolerance induction in clinical transplantation. Transpl Immunol 2004 13 : 117.
14. Woodruff MF, Lennox B. Reciprocal skin grafts in a pair of twins showing blood chimaerism. Lancet 1959 2 : 476.
15. Achauer BM, Hewitt CW, Black KS, et al. Long-term skin allograft survival after short-term cyclosporin treatment in a patient with massive burns. Lancet 1986 1 : 14.
16. Sheil AG, Moseley RV, Murray JE. Differential skin and renal homograft survival in dogs on immunosuppressive therapy. Surg Forum 1964 15 : 166.
17. Lee WP, Yaremchuk MJ, Pan YC, Randolph MA, Tan CM, Weiland AJ. Relative antigenicity of components of a vascularized limb allograft. Plast Reconstr Surg 1991 87 : 401.
18. Steinmuller D. The enigma of skin allograft rejection. Transplant. Rev. 1998 12 : 42.
19. Bushell A, Liddington ML, Morris PJ Directly vascularized skin grafts are more immunogenic than whole organ allografts: a novel study in a CD4 tolerance model. Abstracts of the 4th Basic Sciences Symposium of the Transplantation Society, Noordwijkerhout, 995 p 400. 1995.
20. Medawar PB. The behaviour and fate of skin autografts and skin homografts in rabbits: a report to the War Wounds Committee of the Medical Research Council. J Anat 1944 78 : 176.
21. Steinmuller D. Passive transfer of immunity to skin homografts in rats. Ann N Y Acad Sci 1962 99 : 629.
22. Saiki T, Ezaki T, Ogawa M, Matsuno K. Trafficking of host- and donor-derived dendritic cells in rat cardiac transplantation: allosensitization in the spleen and hepatic nodes. Transplantation 2001 71 : 1806.
23. Barker CF, Billingham RE. The role of afferent lymphatics in the rejection of skin homografts. J Exp Med 1968 128 : 197.
24. Tilney NL, Gowans JL. The sensitization of rats by allografts transplanted to alymphatic pedicles of skin. J Exp Med 1971 133 : 951.
25. Larsen CP, Barker H, Morris PJ, Austyn JM. Failure of mature dendritic cells of the host to migrate from the blood into cardiac or skin allografts. Transplantation 1990 50 : 294.
26. Ochando JC, Krieger NR, Bromberg JS. Direct versus indirect allorecognition: visualization of dendritic cell distribution and interactions during rejection and tolerization. Am J Transplant 2006 6 : 2488.
27. Emmanouilidis N, Guo Z, Dong Y, et al. Immunosuppressive and trafficking properties of donor splenic and bone marrow dendritic cells. Transplantation 2006 81 : 455.
28. Moser M. Dendritic cells in immunity and tolerance-do they display opposite functions? Immunity 2003 19 : 5.
29. Perloff LJ, Barker CF. The immediately vascularized skin allograft. Transplantation 1979 28 : 125.
30. Boyse EA, Old LJ. Loss of skin allograft tolerance by chimeras. Transplantation 1968 6 : 619.
31. Silverman MS, Chin PH. Differences in the rejection of skin transplants and blood cells of donor marrow origin by radiation-induced chimeras. Ann N Y Acad Sci 1962 99 : 542.
32. Scheid M, Boyse EA, Carswell EA, Old LJ. Serologically demonstrable alloantigens of mouse epidermal cells. J Exp Med 1972 135 : 938.
33. Zhang Z, Zhu L, Quan D, et al. Pattern of liver, kidney, heart, and intestine allograft rejection in different mouse strain combinations. Transplantation 1996 62 : 1267.
34. Goss JA, Nakafusa Y, Flye MW. Prolongation of small bowel allografts after intrathymic injection of donor alloantigen and ALS. J Surg Res 1993 54 : 494.
35. Prop J, Nieuwenhuis P, Wildevuur CR. Lung allograft rejection in the rat. I. Accelerated rejection caused by graft lymphocytes. Transplantation 1985 40 : 25.
36. Bos JD, Das PK, Kapsenberg ML. The skin immune system (SIS). In : Bos JD, ed. Skin Immune System (SIS). Boca Raton : CRC Press, 1997 : 9.
37. Chen HD, Silvers WK. Influence of Langerhans cells on the survival of H-Y incompatible skin grafts in rats. J Invest Dermatol 1983 81 : 20.
38. Mathieson BJ, Flaherty L, Bennett D, Boyse EA. Differences in the rejection of trunk skin and tail skin allografts involving weak histocompatibility loci. Transplantation 1975 19 : 525.
39. Sena J, Wachtel SS, Murphy G. A comparison of the survival of H-Y incompatible ear, tail, and body skin grafts. Transplantation 1976 21 : 412.
40. Bergstresser PR, Fletcher CR, Streilein JW. Surface densities of Langerhans cells in relation to rodent epidermal sites with special immunologic properties. J Invest Dermatol 1980 74 : 77.
41. Illigens BM, Yamada A, Fedoseyeva EV, et al. The relative contribution of direct and indirect antigen recognition pathways to the alloresponse and graft rejection depends upon the nature of the transplant. Hum Immunol 2002 63 : 912.
42. Hoffman DK, Sibley RK, Korman JM, Press BH. Light microscopic and immunohistochemical features in serial biopsies of epidermal versus dermal allografts. Ann Plast Surg 1994 33 : 295.
43. Wu J, Barisoni D, Armato U. An investigation into the mechanisms by which human dermis does not significantly contribute to the rejection of allo-skin grafts. Burns 1995 21 : 11.
44. He C, Schenk S, Zhang Q, et al. Effects of T cell frequency and graft size on transplant outcome in mice. J Immunol 2004 172 : 240.
45. Poggio ED, Hila S, Stephany B, et al. Donor kidney volume and outcomes following live donor kidney transplantation. Am J Transplant 2006 6 : 616.
46. Sanchez-Fructuoso AI, Prats D, Marques M, et al. Does renal mass exert an independent effect on the determinants of antigen-dependent injury? Transplantation 2001 71 : 381.
47. Jones ND, Turvey SE, Van Maurik A, et al. Differential susceptibility of heart, skin, and islet allografts to T cell-mediated rejection. J Immunol 2001 166 : 2824.
48. Sho M, Yamada A, Najafian N, et al. Physiological mechanisms of regulating alloimmunity: cytokines, CTLA-4, CD25 + cells, and the alloreactive T cell clone size. J Immunol 2002 169 : 3744.
49. van Bekkum DW. Conditioning regimens for marrow grafting. Semin Hematol 1984 21 : 81.
50. Kawai T, Andrews D, Colvin RB, Sachs DH, Cosimi AB. Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat Med 2000 6 : 114.
51. Pober JS, Bothwell AL, Lorber MI, McNiff JM, Schechner JS, Tellides G. Immunopathology of human T cell responses to skin, artery and endothelial cell grafts in the human peripheral blood lymphocyte/severe combined immunodeficient mouse. Springer Semin Immunopathol 2003 25 : 167.
52. Houser SL, Benjamin LC, Wain JC, Madsen JC, Allan JS. Constitutive expression of major histocompatibility complex class II antigens in pulmonary epithelium and endothelium varies among different species. Transplantation 2004 77 : 605.
53. Kreisel D, Krupnick AS, Szeto WY, et al. A simple method for culturing mouse vascular endothelium. J Immunol Methods 2001 254 : 31.
54. Grazia TJ, Pietra BA, Johnson ZA, Kelly BP, Plenter RJ, Gill RG. A two-step model of acute CD4 T-cell mediated cardiac allograft rejection. J Immunol 2004 172 : 7451.
55. Krupnick AS, Gelman AE, Barchet W, et al. Murine vascular endothelium activates and induces the generation of allogeneic CD4 + 25 + Foxp3 + regulatory T cells. J Immunol 2005 175 : 6265.
56. Adams AB, Pearson TC, Larsen CP. Heterologous immunity: an overlooked barrier to tolerance. Immunol Rev 2003 196 : 147.
57. Koyama I, Nadazdin O, Boskovic S, et al. Depletion of CD8 memory T cells for induction of tolerance of a previously transplanted kidney allograft. Am J Transplant 2007 7 : 1055.
58. Butler PE, Lee WP, van de Water AP, Randolph MA. Neonatal induction of tolerance to skeletal tissue allografts without immunosuppression. Plast Reconstr Surg 2000 105 : 2424.
59. Cober SR, Randolph MA, Lee WP. Skin allograft survival following intrathymic injection of donor bone marrow. J Surg Res 1999 85 : 204.
60. Petit F, Minns AB, Nazzal JA, et al. Prolongation of skin allograft survival after neonatal injection of donor bone marrow and epidermal cells. Plast Reconstr Surg 2004 113 : 270.
61. Boyse EA, Carswell EA, Scheid MP, Old LJ. Tolerance of Sk-incompatible skin grafts. Nature 1973 244 : 441.
62. Sykes M. Mixed chimerism and transplant tolerance. Immunity 2001 14 : 417.
63. Kurtz J, Wekerle T, Sykes M. Tolerance in mixed chimerism - a role for regulatory cells? Trends Immunol 2004 25 : 518.
64. Domenig C, Sanchez-Fueyo A, Kurtz J, et al. Roles of deletion and regulation in creating mixed chimerism and allograft tolerance using a nonlymphoablative irradiation-free protocol. J Immunol 2005 175 : 51.
65. Bemelman F, Honey K, Adams E, Cobbold S, Waldmann H. Bone marrow transplantation induces either clonal deletion or infectious tolerance depending on the dose. J Immunol 1998 160 : 2645.
66. Waldmann H, Adams E, Fairchild P, Cobbold S. Infectious tolerance and the long-term acceptance of transplanted tissue. Immunol Rev 2006 212 : 301.
67. Qin S, Cobbold SP, Pope H, et al. "Infectious" transplantation tolerance. Science 1993 259 : 974.
68. Chen ZK, Cobbold SP, Waldmann H, Metcalfe S. Amplification of natural regulatory immune mechanisms for transplantation tolerance. Transplantation 1996 62 : 1200.
69. Davies JD, Leong LY, Mellor A, Cobbold SP, Waldmann H. T cell suppression in transplantation tolerance through linked recognition. J Immunol 1996 156 : 3602.
70. Hettiaratchy S, Melendy E, Randolph MA, et al. Tolerance to composite tissue allografts across a major histocompatibility barrier in miniature swine. Transplantation 2004 77 : 514.
71. Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M. Cell migration, chimerism, and graft acceptance. Lancet 1992 339 : 1579.
72. Bonilla WV, Geuking MB, Aichele P, Ludewig B, Hengartner H, Zinkernagel RM. Microchimerism maintains deletion of the donor cell-specific CD8 T cell repertoire. J Clin Invest 2006 116 : 156.
73. Wood K, Sachs DH. Chimerism and transplantation tolerance: cause and effect. Immunol Today 1996 17 : 584.
74. Elwood ET, Larsen CP, Maurer MH, et al. Microchimerism and rejection in clinical transplantation. Lancet 1997 349 : 1358.
75. Fuchimoto Y, Yamada K, Shimizu A, et al. Relationship between chimerism and tolerance in a kidney transplantation model. J Immunol 1999 162 : 5704.
76. Ozmen S, Ulusal BG, Ulusal AE, Izycki D, Yoder B, Siemionow M. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier. Transplant Proc 2006 38 : 1625.
77. Klimczak A, Agaoglu G, Carnevale KA, Siemionow M. Applications of bilateral vascularized femoral bone marrow transplantation for chimerism induction across the major histocompatibility (MHC) barrier: part II. Ann Plast Surg 2006 57 : 422.
78. Mathes DW, Randolph MA, Bourget JL, et al. Recipient bone marrow engraftment in donor tissue after long-term tolerance to a composite tissue allograft. Transplantation 2002 73 : 1880.
79. Frame JD, Sanders R, Goodacre TE, Morgan BD. The fate of meshed allograft skin in burned patients using cyclosporin immunosuppression. Br J Plast Surg 1989 42 : 27.
80. Utsugi R, Barth RN, Lee RS, et al. Induction of transplantation tolerance with a short course of tacrolimus (FK506): I. Rapid and stable tolerance to two-haplotype fully mhc-mismatched kidney allografts in miniature swine. Transplantation 2001 71 : 1368.
81. Demir Y, Ozmen S, Klimczak A, Mukherjee AL, Siemionow MZ. Strategies to develop chimerism in vascularized skin allografts across MHC barrier. Microsurgery 2005 25 : 415.
82. Zheng XX, Sanchez-Fueyo A, Sho M, Domenig C, Sayegh MH, Strom TB. Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance. Immunity 2003 19 : 503.
83. Qin SX, Cobbold S, Benjamin R, Waldmann H. Induction of classical transplantation tolerance in the adult. J Exp Med 1989 169 : 779.
84. Preville X, Flacher M, LeMauff B, et al. Mechanisms involved in antithymocyte globulin immunosuppressive activity in a nonhuman primate model. Transplantation 2001 71 : 460.
85. Jarvinen LZ, Blazar BR, Adeyi OA, Strom TB, Noelle RJ. CD154 on the surface of CD4 + CD25 + regulatory T cells contributes to skin transplant tolerance. Transplantation 2003 76 : 1375.
86. Larsen CP, Elwood ET, Alexander DZ, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996 381 : 434.
87. Xu H, Montgomery SP, Preston EH, et al. Studies investigating pretransplant donor-specific blood transfusion, rapamycin, and the CD154-specific antibody IDEC-131 in a nonhuman primate model of skin allotransplantation. J Immunol 2003 170 : 2776.
88. Elster EA, Xu H, Tadaki DK, et al. Primate skin allotransplantation with anti-CD154 monotherapy. Transplant Proc 2001 33 : 675.
89. Elster EA, Xu H, Tadaki DK, et al. Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates. Transplantation 2001 72 : 1473.
90. Habicht A, Najafian N, Yagita H, Sayegh MH, Clarkson MR. New Insights in CD28-Independent Allograft Rejection. Am J Transplant 2007 7 : 1917.
91. Demirci G, Amanullah F, Kewalaramani R, et al. Critical role of OX40 in CD28 and CD154-independent rejection. J Immunol 2004 172 : 1691.
92. Hayashi S, Peranteau WH, Shaaban AF, Flake AW. Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte infusion. Blood 2002 100 : 804.
93. Kim HB, Shaaban AF, Yang EY, Liechty KW, Flake AW. Microchimerism and tolerance after in utero bone marrow transplantation in mice. J Surg Res 1998 77 : 1.
94. Mathes DW, Solari MG, Randolph MA, et al. Long-term acceptance of renal allografts following prenatal inoculation with adult bone marrow. Transplantation 2005 80 : 1300.
95. Baron C, McMorrow I, Sachs DH, LeGuern C. Persistence of dominant T cell clones in accepted solid organ transplants. J Immunol 2001 167 : 4154.
96. Jonker M, van den HY, Noort RC, et al. Immunomodulation by intrathymic injection of donor leukocytes in rhesus monkeys. Transplantation 2001 72 : 1432.
97. van Vreeswijk W, Balner H. Major histocompatibility complex matching and other factors influencing skin allograft survival in related and unrelated rhesus monkeys. Transplantation 1980 30 : 196.
98. Bushell A, Karim M, Kingsley CI, Wood KJ. Pretransplant blood transfusion without additional immunotherapy generates CD25 + CD4 + regulatory T cells: a potential explanation for the blood-transfusion effect. Transplantation 2003 76 : 449.
99. Lee WP, Rubin JP, Bourget JL, et al. Tolerance to limb tissue allografts between swine matched for major histocompatibility complex antigens. Plast Reconstr Surg 2001 107 : 1482.
100. Lee WP, Rubin JP, Cober S, Ierino F, Randolph MA, Sachs DH. Use of swine model in transplantation of vascularized skeletal tissue allografts. Transplant Proc 1998 30 : 2743.
101. Mathes DW, Randolph MA, Solari MG, et al. Split tolerance to a composite tissue allograft in a swine model. Transplantation 2003 75 : 25.
102. Roussey-Kesler G, Giral M, Moreau A, et al. Clinical operational tolerance after kidney transplantation. Am J Transplant 2006 6 : 736.
103. Main JM, Prehn RT. Successful skin homografts after the administration of high dosage X radiation and homologous bone marrow. J Natl Cancer Inst 1955 15 : 1023.
104. Tillson M, Niemeyer GP, Welch JA, et al. Hematopoietic chimerism induces renal and skin allograft tolerance in DLA-identical dogs. Exp Hematol 2006 34 : 1759.
105. Yunusov MY, Kuhr CS, Georges GE, et al. Partial donor-specific tolerance to delayed skin grafts after rejection of hematopoietic cell graft. Transplantation 2006 82 : 629.
106. Cobbold SP, Martin G, Qin S, Waldmann H. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature 1986 323 : 164.
107. Fuchimoto Y, Gleit ZL, Huang CA, et al. Skin-specific alloantigens in miniature swine. Transplantation 2001 72 : 122.
108. Ozer K, Oke R, Gurunluoglu R, et al. Induction of tolerance to hind limb allografts in rats receiving cyclosporine A and antilymphocyte serum: effect of duration of the treatment. Transplantation 2003 75 : 31.
109. Siemionow M, Ortak T, Izycki D, et al. Induction of tolerance in composite-tissue allografts. Transplantation 2002 74 : 1211.
110. Siemionow MZ, Izycki DM, Zielinski M. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol. Transplantation 2003 76 : 1662.
111. Siemionow M, Ulusal BG, Ozmen S, Ulusal AE, Ozer K. Composite vascularized skin/bone graft model: a viable source for vascularized bone marrow transplantation. Microsurgery 2004 24 : 200.
112. Siemionow M, Izycki D, Ozer K, Ozmen S, Klimczak A. Role of thymus in operational tolerance induction in limb allograft transplant model. Transplantation 2006 81 : 1568.
113. Qin SX, Wise M, Cobbold SP, et al. Induction of tolerance in peripheral T cells with monoclonal antibodies. Eur J Immunol 1990 20 : 2737.
114. Huang CA, Yamada K, Murphy MC, et al. In vivo T cell depletion in miniature swine using the swine CD3 immunotoxin, pCD3-CRM9. Transplantation 1999 68 : 855.
115. Doody DP, Stenger KS, Winn HJ. Immunologically nonspecific mechanisms of tissue destruction inX the rejection of skin grafts.X. J Exp Med 1994 179 : 1645.
116. Wekerle T, Sayegh MH, Ito H, et al. Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance. Transplantation 1999 68 : 1348.
117. Wekerle T, Kurtz J, Ito H, et al. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat Med 2000 6 : 464.
118. Durham MM, Bingaman AW, Adams AB, et al. Cutting edge: administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning. J Immunol 2000 165 : 1.
119. Seung E, Mordes JP, Rossini AA, Greiner DL. Hematopoietic chimerism and central tolerance created by peripheral-tolerance induction without myeloablative conditioning. J Clin Invest 2003 112 : 795.
120. Wekerle T, Kurtz J, Bigenzahn S, Takeuchi Y, Sykes M. Mechanisms of transplant tolerance induction using costimulatory blockade. Curr Opin Immunol 2002 14 : 592.
121. Nguyen VT, Taieb A, Sacks JM, et al. Allopeptide-pulsed dendritic cells and composite tissue allograft survival. Microsurgery 2007 27 : 105.
122. Garrovillo M, Ali A, DePaz HA, et al. Induction of transplant tolerance with immunodominant allopeptide-pulsed host lymphoid and myeloid dendritic cells. Am J Transplant 2001 1 : 129.
123. Beriou G, Peche H, Guillonneau C, Merieau E, Cuturi MC. Donor-specific allograft tolerance by administration of recipient-derived immature dendritic cells and suboptimal immunosuppression. Transplantation 2005 79 : 969.
124. Markees TG, Phillips NE, Gordon EJ, et al. Prolonged skin allograft survival in mice treated with Flt3-ligand-induced dendritic cells and anti-CD154 monoclonal antibody. Transplant Proc 1999 31 : 884.